Case C-557/16, Astellas Pharma – measuring the data exclusivity period on a marketing authorisation [judgment 2018, ECLI:EU:C:2018:181]
By judgment of 14 March 2018 (ECLI:EU:C:2018:181) the Court ruled, in the words of the operative part: “1.
Tag
marketing authorisation
5 case reports
Case C-567/16, Merck Sharp – SPC Lazarus law [judgment 2017, ECLI:EU:C:2017:948]
By judgment of 7 December 2017 (ECLI:EU:C:2017:948) the Court ruled, in the words of the operative part: “1.
Case C-179/16, Hoffmann-La Roche – is off-label medicine use, off-limits to EU cartel law? [judgment 2018, ECLI:EU:C:2018:25]
By judgment of 23 January 2018 (ECLI:EU:C:2018:25) the Court ruled, in the words of the operative part: “1.
Case C-276/15, Hecht-Pharma – incensed at the competition in Frankincense-extract capsules [judgment 2016, ECLI:EU:C:2016:801]
By judgment of 26 October 2016 (ECLI:EU:C:2016:801) the Court held that a product whose essential manufacturing steps are carried out in a pharmacy as part of its normal business, producing up to 100 dispensing-ready packages a day, is not prepared…
Case C-114/15, AUDACE – audacious French farmers buy Spanish veterinary medicinal products [judgment 2016, ECLI:EU:C:2016:813]
By judgment of 27 October 2016 (ECLI:EU:C:2016:813) the Court held that Articles 34 and 36 TFEU preclude national rules reserving parallel imports of veterinary medicinal products to authorised wholesalers, thereby excluding farmers who import for their…